antifungal therapy – Page 13

Localized Versus Diffuse Corneal Invasion in Fungal Keratitis: Histological Insights from Candida albicans and Fusarium falciforme

mycolabadmin

This study compared how two different fungi invade the cornea (clear part of the eye) by examining tissue samples from patients who had severe eye infections. Candida stayed in one small area while Fusarium spread throughout the entire cornea tissue. The findings suggest that different fungi behave very differently when infecting the eye, which could help doctors choose better treatments. Understanding these differences may explain why Fusarium infections are much harder to treat with medications alone.

The 2024 International Society for Human and Animal Mycology (ISHAM)-ABPA working group guidelines: Transforming diagnosis and management of ABPA

mycolabadmin

Allergic bronchopulmonary aspergillosis (ABPA) is a serious lung condition that develops when people with asthma have an allergic reaction to Aspergillus fungus. New international guidelines now provide better ways to diagnose and treat this condition, making it easier for doctors to identify ABPA early and prescribe the right treatment to prevent serious lung damage like bronchiectasis.

Odontogenic-onset mucormycosis: A case series from a tertiary care institute in North India

mycolabadmin

Mucormycosis is a serious fungal infection that can develop after dental procedures like tooth extraction or root canal therapy, especially in people with poorly controlled diabetes. This case study from India describes five patients who developed this infection within weeks of dental work. The infection destroys bone in the upper jaw and palate but usually doesn’t spread to the sinuses like other forms of mucormycosis. All patients improved with antifungal medications and surgical cleaning, highlighting the importance of proper sterilization during dental procedures.

Enhancing antifungal stewardship: The educational and healthcare benefits of involving pharmacy students in audits

mycolabadmin

This study involved pharmacy students in reviewing fluconazole prescriptions at two Sydney hospitals to improve antifungal medication use. The researchers found that many fluconazole prescriptions were not being used appropriately, and some patients had dangerous drug interactions. The pharmacy students gained valuable real-world experience while helping the hospitals improve their antifungal stewardship practices.

In vitro and in vivo inhibitory effects and transcriptional reactions of graphene oxide on Verticillium dahliae

mycolabadmin

Graphene oxide, a nanomaterial derived from graphene, effectively inhibits the growth of Verticillium dahliae, a fungus that causes devastating wilt disease in cotton and many other plants. The study shows that graphene oxide damages the fungal cell membrane and disrupts key metabolic processes, preventing the fungus from growing and infecting plants. When applied to cotton plants, graphene oxide treatment significantly reduced wilt disease symptoms, suggesting it could be a promising alternative to chemical fungicides for controlling this important agricultural disease.

Roles of the Sec2p Gene in the Growth and Pathogenicity Regulation of Aspergillus fumigatus

mycolabadmin

Scientists studied a gene called Sec2p in a harmful fungus that causes serious lung infections in people with weak immune systems. When they removed this gene, the fungus grew more slowly and was much less dangerous to infected mice, with 67% of mice surviving compared to only 22% with normal fungus. The gene controls how the fungus breaks down its own cell parts for nutrition and repairs its cell wall, so blocking it weakens the fungus significantly.

Comparison of the Filamentous Fungi Library v4.0 MALDI Biotyper Platform vs MSI-2 performance for identifying filamentous fungi from liquid cultures

mycolabadmin

This study compared two advanced technologies for identifying dangerous fungi in clinical samples. The MALDI Biotyper FFLv4.0 system identified about 96% of fungi correctly when using liquid culture samples, outperforming the MSI-2 database which identified about 78.5%. Both systems had difficulty with certain difficult-to-distinguish species, especially within Aspergillus and Fusarium groups, but performed well with Mucorales fungi. The findings suggest that continuous updating of these fungal identification libraries is essential for improving patient care.

Schizophyllum radiatum: An uncommon culprit of invasive fungal rhinosinusitis in an immunocompetent patient – A case report from India

mycolabadmin

A 32-year-old healthy woman in India developed a serious fungal infection in her sinuses caused by an unusually rare fungus called Schizophyllum radiatum. Doctors removed the infected material through surgery and identified the fungus using genetic sequencing when standard methods failed. Treatment with antifungal medication successfully cleared the infection, and the patient fully recovered.

Assessing Diagnostic Capabilities and Treatment Accessibility for Invasive Fungal Infections in the Balkan Region

mycolabadmin

Researchers surveyed medical centers across 12 Balkan countries to understand how well-equipped they are to diagnose and treat serious fungal infections. They found that while most centers have basic laboratory tools like microscopes and cultures, advanced molecular tests for identifying fungal species are less common. Antifungal medications like triazoles are widely available, but other important treatment options are harder to find in the region.

Sarocladium implicatum: an unusual agent of opportunistic infection in a COVID-19 patient

mycolabadmin

A 64-year-old man hospitalized with COVID-19 developed a serious fungal infection from Sarocladium implicatum, an unusual fungus rarely found in humans. The infection appeared in his bloodstream and lungs while his immune system was severely weakened by the virus and medications. Doctors identified the fungus using genetic testing and successfully treated him with voriconazole antifungal medication. This case highlights how COVID-19 patients in intensive care are vulnerable to rare opportunistic infections that require specialized laboratory testing to identify and treat.

Research Keyword: antifungal therapy